Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

Clinical trial NCT00578175 · COMPLETED

Trial details

NCT number: NCT00578175
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Varicella Rubella Mumps Measles

Start date: 2007-11-20
Primary completion: 2009-02-24
Enrollment: 1851

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.